BR9509986A - Uso de agentes antivirais aminopurina para o tratamento e profilaxia de infecções de vírus de herpes latentes - Google Patents

Uso de agentes antivirais aminopurina para o tratamento e profilaxia de infecções de vírus de herpes latentes

Info

Publication number
BR9509986A
BR9509986A BR9509986A BR9509986A BR9509986A BR 9509986 A BR9509986 A BR 9509986A BR 9509986 A BR9509986 A BR 9509986A BR 9509986 A BR9509986 A BR 9509986A BR 9509986 A BR9509986 A BR 9509986A
Authority
BR
Brazil
Prior art keywords
prophylaxis
treatment
herpes virus
antiviral agents
virus infections
Prior art date
Application number
BR9509986A
Other languages
English (en)
Inventor
Hugh John Field
Alana Maureen Tchackray
Teresa Helen Bacon
David Sutton
Richard Anthony Vere Hodge
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27451235&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9509986(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9425012.3A external-priority patent/GB9425012D0/en
Priority claimed from GBGB9506663.5A external-priority patent/GB9506663D0/en
Priority claimed from GBGB9517308.4A external-priority patent/GB9517308D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of BR9509986A publication Critical patent/BR9509986A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR9509986A 1994-12-12 1995-11-23 Uso de agentes antivirais aminopurina para o tratamento e profilaxia de infecções de vírus de herpes latentes BR9509986A (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB9425012.3A GB9425012D0 (en) 1994-12-12 1994-12-12 Pharmaceuticals
GBGB9506663.5A GB9506663D0 (en) 1995-03-31 1995-03-31 Pharmaceuticals
GBGB9517308.4A GB9517308D0 (en) 1995-08-24 1995-08-24 Pharmaceuticals
US08/522,790 US5840763A (en) 1994-12-12 1995-09-01 Treatment of a latent infection of herpes viruses
PCT/EP1995/004692 WO1996018396A1 (en) 1994-12-12 1995-11-23 Use of aminopurine antiviral agents for the treatment and prophylaxis of latent herpesvirus infections

Publications (1)

Publication Number Publication Date
BR9509986A true BR9509986A (pt) 1997-11-25

Family

ID=27451235

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9509986A BR9509986A (pt) 1994-12-12 1995-11-23 Uso de agentes antivirais aminopurina para o tratamento e profilaxia de infecções de vírus de herpes latentes

Country Status (24)

Country Link
US (2) US5840763A (pt)
EP (1) EP0799039B1 (pt)
JP (1) JP2008088189A (pt)
CN (1) CN1098687C (pt)
AP (1) AP669A (pt)
AT (1) ATE208198T1 (pt)
AU (1) AU699627B2 (pt)
BG (1) BG63815B1 (pt)
BR (1) BR9509986A (pt)
CA (1) CA2207503C (pt)
CY (1) CY2339B1 (pt)
CZ (1) CZ291545B6 (pt)
DE (1) DE69523776T2 (pt)
DK (1) DK0799039T3 (pt)
ES (1) ES2166834T3 (pt)
HK (1) HK1003259A1 (pt)
HU (1) HU222835B1 (pt)
NO (1) NO313862B1 (pt)
NZ (1) NZ297424A (pt)
PT (1) PT799039E (pt)
RO (1) RO120042B1 (pt)
SI (1) SI0799039T1 (pt)
SK (1) SK282983B6 (pt)
WO (1) WO1996018396A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840763A (en) * 1994-12-12 1998-11-24 Smithkline Beecham Plc Treatment of a latent infection of herpes viruses
US6047209A (en) * 1999-04-02 2000-04-04 Denny; Jeffrey Paul Method and apparatus for maintenance of pierced orifices
AU2006230269A1 (en) * 2005-03-30 2006-10-05 Novartis Ag Penciclovir or famciclovir for the treatment of recurrent genital herpes with a one-day application
MX2007012104A (es) * 2005-03-30 2008-03-11 Novartis Ag Penclovir o famciclovir para el tratamiento de herpes genital recurrente con una aplicacion de un dia.
US20100136106A1 (en) * 2005-06-08 2010-06-03 Gary Liversidge Modified Release Famciclovir Compositions
EP3753563A1 (en) * 2019-06-20 2020-12-23 Helmholtz-Zentrum für Infektionsforschung GmbH Anti-herpesvirus guanosine analogue for the inhibition of basal autophagy

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4355032B2 (en) * 1981-05-21 1990-10-30 9-(1,3-dihydroxy-2-propoxymethyl)guanine as antiviral agent
US4423050A (en) * 1981-05-21 1983-12-27 Syntex (U.S.A.) Inc. 9-(1,3-Dihydroxy-2-propoxymethyl)guanine as antiviral agent
US4461757A (en) * 1983-02-23 1984-07-24 Ens Bio Logicals Inc. Dimethylaminomethylenated anti-herpes compounds
DE3485225D1 (de) * 1983-08-18 1991-12-05 Beecham Group Plc Antivirale guanin-derivate.
GB9015051D0 (en) * 1990-07-07 1990-08-29 Beecham Group Plc Pharmaceutical treatment
US5840763A (en) * 1994-12-12 1998-11-24 Smithkline Beecham Plc Treatment of a latent infection of herpes viruses

Also Published As

Publication number Publication date
SK75197A3 (en) 1997-11-05
CZ179997A3 (en) 1997-09-17
NO313862B1 (no) 2002-12-16
BG101608A (en) 1998-02-27
AP9701001A0 (en) 1997-07-31
NO972688D0 (no) 1997-06-11
SK282983B6 (sk) 2003-01-09
JP2008088189A (ja) 2008-04-17
EP0799039A1 (en) 1997-10-08
ES2166834T3 (es) 2002-05-01
CN1098687C (zh) 2003-01-15
HUT77437A (hu) 1998-04-28
DK0799039T3 (da) 2002-01-28
DE69523776D1 (de) 2001-12-13
PT799039E (pt) 2002-04-29
CZ291545B6 (cs) 2003-04-16
HU222835B1 (hu) 2003-11-28
WO1996018396A1 (en) 1996-06-20
CY2339B1 (en) 2004-02-06
EP0799039B1 (en) 2001-11-07
CA2207503A1 (en) 1996-06-20
AP669A (en) 1998-09-04
BG63815B1 (bg) 2003-02-28
US5840763A (en) 1998-11-24
RO120042B1 (ro) 2005-08-30
AU699627B2 (en) 1998-12-10
ATE208198T1 (de) 2001-11-15
MX9704336A (es) 1997-09-30
NO972688L (no) 1997-08-07
CN1175212A (zh) 1998-03-04
NZ297424A (en) 2000-07-28
DE69523776T2 (de) 2002-08-01
AU4257896A (en) 1996-07-03
CA2207503C (en) 2006-07-18
US5916893A (en) 1999-06-29
SI0799039T1 (en) 2002-06-30
HK1003259A1 (en) 1998-10-23

Similar Documents

Publication Publication Date Title
BR9608758A (pt) Uso de ribavirina e interferom alfa para o tratamento de hepatite c
BR9706968A (pt) Uso de antagonistas de alfa-ppar e gama-ppar para o tratamento de sindrome x
EE9800382A (et) Lihtherpese viiruse ja teiste nakkushaiguste antimikroobne ravimenetlus
PT877716E (pt) Composicoes de vidro bioactivo para uso no tratamento de estruturas dentais
HK77989A (en) Compositions comprising interferon and their therapeutic use
AP9300603A0 (en) Use of dideoxy nucleoside analogues in the treatment of viral infections
GB9709360D0 (en) Methods for the treatment of herpes virus infections
BR9609695A (pt) Composição herbicida sinérgica e processo para seu uso
EE03924B1 (et) Karbotsükliline nukleosiidhemisulfaat ja selle kasutamine viirusinfektsioonide raviks
BR9509986A (pt) Uso de agentes antivirais aminopurina para o tratamento e profilaxia de infecções de vírus de herpes latentes
GB8926595D0 (en) Pharmaceutical compositions for use in the treatment herpes simplex virus infections
AU647807B2 (en) Penciclovir and famciclovir and related guanine derivatives for the treatment of the HIV-1 infections
NO983402D0 (no) Nukeosidanaloger i kombinasjonsterapi av herpes simplex infeksjoner
EP0546261A3 (en) Method of treating latent herpes viral infections
PT804199E (pt) Uso de penciclovir para o tratamento de nevralgias pos-herpeticas
GB9419692D0 (en) Treatment of herpes infections
BR9406575A (pt) Método de combater infecçoes virais de herpes simplex aciclovir-resistentes
ITMI912290A0 (it) Miscele di n-alchilftalimmidi, loro preparazione e loro impiego
MX9102245A (es) Combinaciones de compuestos vainilloides y compuestos antivirales de nucleosido para el tratamiento de infecciones de herpes
IT8922804A0 (it) Fattori di crescita fibroblastici per l'uso nella prevenzione e nel trattamento di infezioni virali
BR9607225A (pt) Uso de composto preparação farmacêutica e processo para profilaxia ou para o tratamento de restenose em mamíferos inclusive seres humanos
BR0012380A (pt) 2-amino-benzoxazinonas para o tratamento de vìrus do herpes simples
BR9300468A (pt) Processo para preparacao de 2-hidroxi-4,6-diaril-1,3,5-triazinas e utilizacao
PT82258B (pt) Processo de preparacao de composicoes compreendendo interferao humano e nonilfenoxipolietanol para o tratamento de infeccoes virais por herpes simplex em humanos
IT1298164B1 (it) Impiego di allantoina come unico principio attivo antivirale per il trattamento e la profilassi dell'herpes simplex

Legal Events

Date Code Title Description
FC Decision: refusal
CKFC Appeal: appeal against refusal
B25A Requested transfer of rights approved

Owner name: NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD. (BM)

Free format text: TRANSFERIDO DE: SMITHKLINE BEECHAM P.L.C.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08H Application fees: decision cancelled [chapter 8.8 patent gazette]